The Publication Highlights Committee will present an interesting research article from the field of neuromuscular diseases each month. In this section, research data is presented on the WMS website to make it more accessible to the WMS community. The aim is to improve networking among the members of the WMS and to give a face to the researchers in the field. Current published articles can be suggested for publication highlight by the authors themselves or others via email@example.com. In addition, there is the possibility to present oneself and one's research work in a short video. There are no limits to your creativity!
Institute of Neuropathology, Giessen, Germany
Anne Schänzer is head of the diagnostic and research neuromuscular lab. She is specializing on morphology of skeletal and cardiac muscle including electron microscopy and her research focus are genetic and acquired neuromuscular disorders in children and adults.
The Abigail Wexner Research Institute at Nationwide Children, Dublin, United States
Lindsay Alfano is an assistant professor in The Abigail Wexner Research Institute at Nationwide Children’s Hospital. She is a physical therapist specializing in outcome measure administration, selection, and development for patients with neuromuscular diseases.
Université de Versailles, Montigny-le-Bretonneux, France
Helge Amthor is Professor of Pediatric Neurology at the Paris-Saclay University. His research focuses on pathophysiological questions of Duchenne muscular dystrophy.
Institute of Neurology, London, United Kingdom
Enrico Bugiardini main research interests are genetic investigations in neuromuscular diseases and clinical studies in Facioscapulohumeral muscular dystrophy (FSHD). He carries out clinical activity for Muscle Diseases and Mitochondrial Disorders at Queen Square, London for Neuromuscular Diseases.
Hospital for Sick Children, Toronto, Canada
Jim Dowling is a pediatric neurologist and senior scientist at the Hospital for Sick Children in Toronto, Canada. His research is focused on gene discovery and therapy development for congenital myopathies.
Monash University, Clayton, Australia
Meagan McGrath research interests focuses on autophagic pathways in skeletal muscle homeostasis, disease and exercise capacity. She is also interested in understanding the pathomechanism(s) and devising treatments for disorders linked to mutations in the FHL1 gene (termed “FHL1 myopathies”).
Friedrich Baur Institut - Ludwig-Maximilians University , München, Germany
Federica Montagnese's research focus is on the clinical and myopathological aspects of metabolic myopathies, myotonic syndromes and muscular dystrophies. She is responsible for the maintenance of the National Registries for myotonic dystrophies and FSHD. She is member of the EAN Subspecialty Panels of “Neurogenetics” and “Muscle disorders”.
Siriraj Hospital, Mahidol University, Bangkok Noi -Bangkok , Thailand
Dr. Jantima Tanboon is an assistant professor of anatomical pathology at Siriraj Hospital, Mahidol University, Thailand. Dr.Tanboon was a research student and a postdoctoral research fellow at the Department of Neuromuscular Research at the National Center of Neurology and Psychiatry (NCNP), Japan under the supervision of Dr.Satoru Noguchi and Dr.Ichizo Nishino where she grew in depth passion in neuromuscular research. Dr.Tanboon is one of a few specialists in her country responsible for muscle biopsy diagnosis.
Nationwide Childrens Hospital, COLUMBUS OHIO, United States
Nicolas Wein worked as a postdoc in the team of Pr. Kevin Flanigan in The Center for Gene Therapy in USA. He started his own group 2016 and works on neuromuscular disorders such as DMD and myotonic dystrophy type 1 and is interested in adeno associated viral treatments.
21 Jun 2022 Type I interferon in dermatomyositis: Impact on myogenesis and possible autocrine/paracrine effect
19 May 2022 Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy
21 Apr 2022 Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
10 Jan 2022 Exploring new therapeutic approaches in FSHD by small molecules modulation of endogenous microRNA